Good advice Stotes. I will. If you are correct, it means there is sufficient slack in the critical path for the FDA timetable to accommodate the additional Stage 3 work. If so, it means that the process to get to agreement on the endpoints for the validation trial is quite long. As you suggest, I will check with Scott. Cheers.
Good advice Stotes. I will. If you are correct, it means there...
-
- There are more pages in this discussion • 483 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.02 |
Change
-0.085(4.04%) |
Mkt cap ! $172.7M | |||
| Open | High | Low | Value | Volume |
| $2.12 | $2.16 | $2.02 | $109.7K | 52.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3111 | $2.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 9873 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| EMV (ASX) Chart |